Zobrazeno 1 - 10
of 104
pro vyhledávání: '"group A meningococcal"'
Autor:
Kimberly Davis, Karen Ford, Rachel Craik, Ushma Galal, Christine S. Rollier, Andrew J. Pollard
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background and rationale The four-component capsular group B meningococcal vaccine (4CMenB) was introduced into the national immunisation schedule in the UK in September 2015 for infants in a 2 + 1 schedule at two, four and 12 months of age.
Externí odkaz:
https://doaj.org/article/2075e45ab32d44f59046dfe096b1af5a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 5, Pp 1103-1106 (2018)
Until recently, periodic Group A meningococcal meningitis outbreaks were a major public health problem in the sub-Saharan Africa. In 2001, the Meningitis Vaccine Project (MVP), a partnership between the World Health Organization (WHO) and PATH, a Sea
Externí odkaz:
https://doaj.org/article/0f6a6f018202449f82dfc05effb2b3fe
Autor:
Rachel Craik, Karen J Ford, Christine S. Rollier, Kimberly Davis, Andrew J. Pollard, Ushma Galal
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Trials
Trials
Background and rationale The four-component capsular group B meningococcal vaccine (4CMenB) was introduced into the national immunisation schedule in the UK in September 2015 for infants in a 2 + 1 schedule at two, four and 12 months of age. A two-do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7df41f6d4e778a470a9d3038fc6765
http://link.springer.com/article/10.1186/s13063-019-3494-1
http://link.springer.com/article/10.1186/s13063-019-3494-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brian D. Plikaytis, Olubukola T. Idoko, Ray Borrow, Helen Findlow, Marie-Pierre Preziosi, Daniel Holme, George M. Carlone, Samba O. Sow
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Sub-Saharan Africa has experienced epidemic cycles of Neisseria meningitidis group A (MenA) disease approximately every 5–10 years, with high disease incidence. One of the worst epidemics occurred in 1996, with greater than 250 000 recorded cases a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc951c91b6a7d8028ce97b9700e74462
https://doi.org/10.1093/cid/civ505
https://doi.org/10.1093/cid/civ505
Autor:
Steven Black, Patrick L.F. Zuber, John W Williams, Abraham Oduro, George Wak, Christine Maure
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. Group A meningococcal disease occurs in large epidemics within the meningitis belt of Africa that includes northern Ghana. Major epidemics in the meningitis belt have infection rates ranging from 100 to 800 per 100 000 population. In 2012
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16b498d56630e55ace835e3bdd292aa
https://doi.org/10.1093/cid/civ625
https://doi.org/10.1093/cid/civ625
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Maternal and neonatal tetanus is still a significant, although vaccine-preventable, cause of morbidity and mortality in many developing countries. When tetanus develops, case-fatality rates are high and treatment is often limited by paucity of resour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed56327c855a45c81f0b40e69a718e1
https://doi.org/10.1093/cid/civ512
https://doi.org/10.1093/cid/civ512
Autor:
Christian Meier, Samba O. Sow, Panchali Roy Chowdhury, Abraham Hodgson, Prasad S. Kulkarni, Godwin Enwere, Brian D. Plikaytis, Hewad Laraway, Marie-Pierre Preziosi, Matthias Niedrig, Yuxiao Tang
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. Yellow fever (YF) is still a major public health problem in endemic regions of Africa and South America. In Africa, one of the main control strategies is routine vaccination within the Expanded Programme on Immunization (EPI). A new menin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b227078c555d9c9eefc37cc619e905
https://doi.org/10.1093/cid/civ603
https://doi.org/10.1093/cid/civ603